Abstract:Endovascular stenting is a safer alternative to open surgery for use in treating cerebral arterial stenosis and significantly reduces the recurrence of ischemic stroke, but the widely used bare-metal stents (BMSs) often result in in-stent restenosis (ISR). Although evidence suggests that drug-eluting stents are superior to BMSs in the short term, their long-term performances remain unknown. Herein, we propose a potential vascular stent modified by immobilizing clickable chemerin 15 (C15) peptides on the stent surface to suppress coagulation and restenosis. Various characterization techniques and an animal model were used to evaluate the surface properties of the modified stents and their effects on endothelial injury, platelet adhesion, and inflammation. The C15-immobilized stent could prevent restenosis by minimizing endothelial injury, promoting physiological healing, restraining the platelet-leukocyte-related inflammatory response, and inhibiting vascular smooth muscle cell proliferation and migration. Furthermore, in vivo studies demonstrated that the C15-immobilized stent mitigated inflammation, suppressed neointimal hyperplasia, and accelerated endothelial restoration. The use of surface-modified, anti-inflammatory, endothelium-friendly stents may be of benefit to patients with arterial stenosis. STATEMENT OF SIGNIFICANCE: Endovascular stenting is increasingly used for cerebral arterial stenosis treatment, aiming to prevent and treat ischemic stroke. But an important accompanying complication is in-stent restenosis (ISR). Persistent inflammation has been established as a hallmark of ISR and anti-inflammation strategies in stent modification proved effective. Chemerin 15, an inflammatory resolution mediator with 15-aa peptide, was active at picomolar through cell surface receptor, no need to permeate cell membrane and involved in resolution of inflammation by inhibiting inflammatory cells adhesion, modulating macrophage polarization into protective phenotype, and reducing inflammatory factors release. The implications of this study are that C15 immobilized stent favors inflammation resolution and rapid re-endothelialization, and exhibits an inhibitory role of restenosis. As such, it helps the decreased incidence of ISR.

OP30 Therapeutic Approach in Endothelial Dysfunction by a Novel Implantable Endogenous Hydrogen Sulfide Loaded Electrospun Fibrous Membranes

Hydrogen Sulfide Releasing and Carboxybetaine Modified Vascular Graft with Enhanced Anticoagulant, Anticalcification, and Pro-Endothelialization Properties

A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release Of Hydrogen Sulfide Reducing Myocardial Fibrosis Via Tgf-Beta 1/Smad Pathway

In vivo inhibition of hypertrophic scars by implantable ginsenoside-Rg3-loaded electrospun fibrous membranes.

Diverse Release Behaviors of Water-Soluble Bioactive Substances from Fibrous Membranes Prepared by Emulsion and Suspension Electrospinning.

Functional Electrospun Fibrous Scaffolds with Dextran-G-poly(l-lysine)-vapg/microrna-145 to Specially Modulate Vascular SMCs

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H2S for Anti-Inflammation and Anticalcification

A Conductive Hydrogen Sulfide-releasing Hydrogel Encapsulating ADSCs for Myocardial Infarction Treatment.

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation

Antimicrobial Surfaces Grafted Random Copolymers With Redv Peptide Beneficial For Endothelialization

Electrospun Membranes of Carboxylated Poly(ester Urethane)urea/gelatin Encapsulating Pterostilbene for Adaptive and Antioxidative Purposes.

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H<sub>2</sub>S for Anti-Inflammation and Anticalcification

Enabling Topical and Long-Term Anti-Radical Properties for Percutaneous Coronary Intervention-Related Complications by Incorporating TEMPOL into Electrospun Nanofibers

S-propargyl-cysteine Delays the Progression of Atherosclerosis and Increases Enos Phosphorylation in Endothelial Cells.

Antimicrobial Surfaces Grafted Random Copolymers with REDV Peptide Beneficial for Endothelialization.

Cardioprotective Effects of a Novel Hydrogen Sulfide Agent-Controlled Release Formulation of S-propargyl-cysteine on Heart Failure Rats and Molecular Mechanisms.

Anti-fouling Coating with ROS-Triggered On-Demand Regulation of Inflammation to Favor Tissue Healing on Vascular Devices

Vascular stent with immobilized anti-inflammatory chemerin 15 peptides mitigates neointimal hyperplasia and accelerates vascular healing

Peptide-modified PELCL Electrospun Membranes for Regulation of Vascular Endothelial Cells.

Improvement of Endothelial Cell Performance in an Optimized Electrospun Pre-polyglycerol Sebacate-Poly Lactic Acid Scaffold for Reconstruction of Intima in Coronary Arteries

Comparative study of nanostructured carriers of calcium phosphate and magnesium phosphate loaded with SRT1720 for the protection of H 2 O 2 -induced senescent endothelium.